ABC | Volume 113, Nº6, December 2019

Short Editorial Santis Renovalvular interaction Arq Bras Cardiol. 2019; 113(6):1112-1113 1. Collet FJ. Précis de pathologie interne. Paris: Gaston Doin & Cie;1930. p. 653–667. 2. Cardio-Renal Connections in Heart Failure and Cardiovascular Disease. Bethesda: National Heart, Lung, and Blood Institute (NHLBI); 2004. 3. Kumar U, Wettersten N, Garimella PS. Cardiorenal Syndrome: Pathophysiology. Cardiol Clin. 2019;37(3):251-65. 4. Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J Jr, Pomerantzeff PM, Laurindo FR. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2008;2(3):463-70. 5. Ternacle J, Côté N, Krapf L, Nguyen A, Clavel MA, Pibarot P. Chronic kidney disease and the pathophysiology of valvular heart disease. Can J Cardiol.2019;35(9):1195-207. 6. Aljohani S, Alqahtani F, Almustafa A, Boobes K, Modi S, Alkhouli M. Trends and outcomes of aortic valve replacement in patients with end-stage renal disease on hemodialysis. Am J Cardiol. 2017;120(9):1626–32. 7. Thourani VH, Forcillo J, Beohar N, Doshi D, Parvataneni R, Ayele GM, et al. Impact of preoperative chronic kidney disease in 2,531 high-risk and inoperable patients undergoing transcatheter aortic valve replacement in the PARTNER Trial. Ann Thorac Surg. 2016;102(4):1172–80. 8. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010;363(17):1597–607. 9. Glaser N, Jackson V, Holzmann MJ. Late survival after aortic valve replacement in patients with moderately reduced kidney function. J Am Heart Assoc. 2016;5(12):pii e004287. 10. Szerlip MZ, Zajarias A, Vemalapalli S, Brennan M, Dai D, Maniar H, et al. Transcatheter aortic valve replacement in patients with end-stage renal disease. J Am Coll Cardiol. 2019;73(22):2806–15. 11. Elhmidi Y, Bleiziffer S, Deutsch MA,Krane M, Mazzitelli D, Piazza N. Acute kidney injury after transcatheter aortic valve implantation: incidence, predictorsand impactonmortality.ArchCardiovascDis.2014;107(2):133–9. 12. Faillace BLR, Ribeiro HB, Campos CM, Truffa AAM, Bernardi FL, Oliveira MDP, et al. Potential of transcatheter aortic valve replacement to improve post-procedure renal function. Cardiovasc Revascularization Med. 2017;18(7):507–11. 13. Azarbal A, Malenka DJ, Huang Y-L, Ross CS, Solomon RJ, DeVries JT, et al. Recovery of kidney disfunction after transcatheter aortic valve implantation (from theNorthernNew England Cardiovascular Disease Study Group). Am J Cardiol. 2018;123(1):426-33. 14. Najjar M, Yerebakan H, Sorabella RA, Guglielmetti L, Vandenberge J, Kurlansky P, et al. Reversibility of chronic kidney disease and outcomes following aortic valve replacement. Interact Cardiovasc Thorac Surg. 2015;21(4):499–505. 15. Calça R, Teles RC, Branco P, Gaspar A, Brito J, Nolasco T et al. Impact of Transcatheter Aortic Valve Implantation on Kidney Function. Arq Bras Cardiol. 2019; 113(6):1104-1111 References This is an open-access article distributed under the terms of the Creative Commons Attribution License 1113